Document is current
Any future updates will be listed below
-
Authors
Flores-Lagunes, L. Leonardo https://orcid.org/0000-0003-1409-3888
Alvarez-Gómez, Rosa María https://orcid.org/0000-0002-5458-7201
Molina-Garay, Carolina https://orcid.org/0000-0003-1633-7938
Jimenez-Olivares, Marco https://orcid.org/0000-0002-5781-8415
Acosta-Mendez, Pablo Arturo https://orcid.org/0009-0005-9107-6549
García-Solorio, Joaquin https://orcid.org/0009-0008-7925-6661
Prida-Riba, Sebastián https://orcid.org/0009-0009-2924-2621
Carillo-Sanchez, Karol https://orcid.org/0000-0002-0079-8476
Mendoza-Caamal, Elvia Cristina https://orcid.org/0000-0002-6224-6829
De la Fuente-Hernández, Marcela Angélica https://orcid.org/0000-0002-2350-7045
Fragoso-Ontiveros, Verónica Zoraya https://orcid.org/0000-0001-6098-197X
Reyes Casarrubias, Rodrigo Estefano https://orcid.org/0000-0003-4404-581X
Alaez-Verson, Carmen https://orcid.org/0000-0003-1042-8505
- License Information
-
More Information
Article History
Received: 8 April 2025
Accepted: 4 August 2025
First Online: 17 September 2025
Declarations
:
: The authors declare no competing interests.
: All procedures involving human participants in this study were conducted per the ethical standards of the institutional and/or national research committee, the 1964 Helsinki Declaration, and its subsequent amendments or comparable ethical standards. This study was approved by the Research and Bioethics Committee of the National Institute of Genomic Medicine in Mexico (approval numbers: 13/2017/E, 22/2018/I, and CEI2017/17).
: All patients signed a written informed consent for germline multi-gene panel testing and agreed to the use of their data for research and statistical purposes. All participants received pre- and post-test genetic counseling by a certified clinical geneticist.
